SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Street Walker who wrote (13)1/28/1999 1:57:00 PM
From: StockMiser  Read Replies (1) | Respond to of 5582
 
I read the original Gunn Allen assessment before the Zicam was announced, and I only just now saw the new press release reiterating the buy rec. I'm really rather suprised he didn't raise his target higher than $24.

But I am 100% positive the target was $24/share, without any hint of a Zicam product.

In any case...that's still almost a 100% upside :-)